Gonda 8-104/Joseph 1-242

Neuro-Immunology
Anastasia Zekeridou, M.D.
"Checkpoint Inhibitors and Paraneoplastic Neurological Autoimmunity"

Learning objectives:
Recognize the manifestations of paraneoplastic neurological autoimmunity in the setting of checkpoint inhibitor treatment
Review the potential mechanisms of neurological paraneoplastic autoimmunity associated to checkpoint inhibitor treatment

The presenter (nor spouse/partner) does not have a relevant financial relationship to disclose and does not intend to discuss an off-label/investigative use of a commercial product/device.